Richa Dua, PharmD is a Senior Medical Director at REVOLUTION Medicines, with previous experience at companies such as Acerta Pharma B.V., Astex Pharmaceuticals, and Genentech. Richa specializes in clinical development of BTK inhibitors in lymphoma, clinical pharmacology, PK data analysis, and PK-PD modeling. Richa holds a Pharm.D degree from Virginia Commonwealth University and completed a Post-Doctoral Fellowship in Clinical PK/PD at the University of North Carolina at Chapel Hill.
Sign up to view 1 direct report
Get started